A Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive Therapy
Randomized Trial of a Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive Therapy
Sponsor: Massachusetts General Hospital
A NA clinical study on Acute Myeloid Leukemia and Myelodysplastic Syndromes, this trial is ongoing. The trial is conducted by Massachusetts General Hospital and has accumulated 14 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
14 versions recorded-
Dec 2025 — Present [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Dec 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jun 2024 — Jul 2024 [monthly]
Recruiting NA
-
Feb 2024 — Jun 2024 [monthly]
Recruiting NA
▶ Show 9 earlier versions
-
Sep 2022 — Feb 2024 [monthly]
Recruiting NA
-
Oct 2021 — Sep 2022 [monthly]
Recruiting NA
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
Jul 2020 — Jan 2021 [monthly]
Recruiting NA
-
Apr 2019 — Jul 2020 [monthly]
Recruiting NA
-
Jan 2019 — Apr 2019 [monthly]
Recruiting NA
-
Jun 2018 — Jan 2019 [monthly]
Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Oct 2017 — Dec 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Massachusetts General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .